1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. Company
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals.

The United States accounts for 75.5% of net sales.

Number of employees : 6 300 people.
Sales per Business
20202021Delta
Distributor1 437.6074.6%2 024.3082.7% +40.81%
Direct489.1025.4%424.2017.3% -13.27%
USD in Million
Sales per region
20202021Delta
United States1 509.5078.3%1 849.4075.5% +22.52%
Non-United States417.2021.7%599.1024.5% +43.6%
USD in Million
Managers
Name Title Age Since
Kevin Sayer Chairman, President & Chief Executive Officer 63 2018
Jereme Sylvain Chief Financial Officer & EVP-Finance 41 -
Andrew Balo EVP-Global Medical Affairs, Access & Evidence 73 -
Jacob Leach Chief Technology Officer & Executive VP 43 -
Donald Abbey Executive VP-IT, Quality & Regulatory Affairs 54 -
Shelly Selvaraj Chief Information Officer & Senior Vice President 62 2021
Barry Regan Executive Vice President-Global Operations 49 2020
Sean Christensen Director-Corporate Affairs & Head-IR - -
Chad M Patterson Executive Vice President-Global Marketing 39 2015
Matt V. Dolan SVP-Strategy, Corporate Development & New Markets 40 -
Members of the board
Name Title Age Since
Kevin Sayer Chairman, President & Chief Executive Officer 63 2018
Jay S. Skyler, Dr. Independent Director 74 2002
Eric J. Topol, Dr. Independent Director 66 2009
Nicholas Augustinos Independent Director 62 2009
Barbara E. Kahn, Dr. Independent Director 68 2011
Steven R. Altman Independent Director 59 2013
Mark G. Foletta Lead Independent Director 60 2015
Richard Alexander Collins Independent Director 64 2017
Bridgette P. Heller Independent Director 59 2019
Karen M. Dahut Independent Director 57 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 98,225,933 97,725,488 99.5% 100,000 0.1% 99.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 10,008,691 10.2%
Baillie Gifford & Co. 4,554,293 4.64%
SSgA Funds Management, Inc. 4,046,782 4.12%
Fidelity Management & Research Co. LLC 3,674,888 3.75%
Sands Capital Management LLC 3,128,590 3.19%
Capital Research & Management Co. (Global Investors) 2,374,545 2.42%
JPMorgan Investment Management, Inc. 2,350,572 2.40%
BlackRock Fund Advisors 2,103,817 2.14%
Stark & Roth LLC 1,887,777 1.92%
Geode Capital Management LLC 1,868,331 1.90%
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 500
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  DXCM.O
- Datastream Code :  
Company contact information
DexCom, Inc.
6340 Sequence Drive
CA 92121 San Diego, California

Phone : +1 858 200-0200
Fax :
web site : https://investors.dexcom.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of DexCom, Inc.
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capi. (M$)
DEXCOM, INC.-37.66%32 847
ABBOTT LABORATORIES-21.93%192 394
MEDTRONIC PLC-0.75%137 736
BECTON, DICKINSON AND COMPANY1.09%70 821
BAXTER INTERNATIONAL INC.-14.92%36 773
HOYA CORPORATION-26.45%35 552
AMERISOURCEBERGEN CORPORATION15.05%32 025
SARTORIUS STEDIM BIOTECH-38.18%28 612
ZIMMER BIOMET HOLDINGS-7.56%24 116
TERUMO CORPORATION-18.66%23 136
WEST PHARMACEUTICAL SERVICES, INC.-34.98%22 591
FUJIFILM HOLDINGS CORPORATION-16.51%22 076
ALIGN TECHNOLOGY, INC.-58.08%21 713
STERIS PLC-11.19%21 645
AVANTOR, INC.-28.69%18 341
BIO-RAD LABORATORIES, INC.-33.55%15 049
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-12.52%14 949
SYSMEX CORPORATION-44.95%13 858
INSULET CORPORATION-25.19%13 803
TELEFLEX INCORPORATED-15.23%13 060
REPLIGEN CORPORATION-43.21%8 337